日出东方控股股份有限公司 2025 年第一次临时股东会资料 日出东方控股股份有限公司 2025 年第一次临时股东会资料 日出东方控股股份有限公司 2025年第一次临时股东会通知重要内容提示 股东会召开日期：2025年10月15日 股权登记日：2025年10月10日 公司代码：603366 公司简称：日出东方 日出东方控股股份有限公司 2025 年第一次临时股东会 会议资料 二〇二五年十月 1/8 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统。 会议登记方法： 1.登记方式：自然人股东须持本人身份证和股东账户卡进行登记；委托代理 人出席会议的，须持代理人本人身份证、授权委托书和股东账户卡进行登记；法 人股东由法定代表人出席会议的，需持营业执照复印件、法定代表人身份证明和 股东账户卡进行登记；由法定代表人委托的代理人出席会议的，须持代理人本人 身份证、营业执照复印件、授权委托书和股东账户卡进行登记；异地股东可以采 用书面信函或传真办理登记，不接受电话登记。 2.登记时间：2025年10月10日（9:00—11:00、14:00—16:00）。 3．登记地点：江苏省连云港市海宁工贸园瀛洲南路199 ...

Core Viewpoint - The article discusses the journey of small investors in the A-share market, highlighting the different phases of market behavior and strategies for maximizing returns, particularly during bull markets and the emergence of "hot stocks" [5][7]. Group 1: Market Phases - The investment journey is divided into three key phases: the "Newbie Village" during the 924 bull market, the "Chaos Period" characterized by the rise of "hot stocks," and the "Ultimate King" phase where investors align with large capital [8][29]. - In the "Newbie Village," investors are encouraged to familiarize themselves with the market mechanisms and identify strong stocks, particularly in a bull market where many stocks are rising [11][8]. - The "Chaos Period" involves navigating a market with multiple main lines and identifying leading stocks, known as "hot stocks," which can yield significant returns [16][18]. Group 2: Investment Strategies - During the "Newbie Village," a hypothetical investment of 50,000 yuan in Tianfeng Securities could grow to 103,500 yuan within a short period, demonstrating the potential for quick gains in a rising market [13]. - In the "Chaos Period," investors can achieve substantial returns by identifying and investing in stocks like Shuangcheng Pharmaceutical and Risheng Dongfang, which saw significant price increases due to market narratives and trends [19][20]. - The article emphasizes the importance of understanding market narratives and the emotional dynamics of trading, as these factors can drive stock prices significantly [24]. Group 3: Role of Large Capital - The "Ultimate King" phase highlights the dominance of large capital in the market, with institutional investors and state-owned funds playing a crucial role in stabilizing and driving market trends [30][31]. - Large capital is increasingly focused on technology stocks, which have shown substantial growth potential, contrasting with traditional sectors that have limited growth prospects [34][38]. - The article notes that successful investments in the current market environment require aligning with large capital and understanding the underlying fundamentals of technology-driven companies [39][42].

Core Viewpoint - The company received a warning letter from the Jiangsu Securities Regulatory Bureau due to non-compliance with information disclosure regulations related to non-operating fund occupation by its controlling shareholder and related parties [1][2]. Group 1: Warning Letter Details - The warning letter indicates that from April 2024 to December 2024, the company's subsidiary provided loans totaling 27.5863 million yuan to a subsidiary of its controlling shareholder, with a remaining balance of 551,600 yuan by the end of 2024 [1][2]. - The company failed to timely disclose this information, which constitutes a violation of the Information Disclosure Management Measures and relevant regulatory guidelines [2]. Group 2: Responsibilities and Actions - Key executives, including the chairman and general manager, were found primarily responsible for the violations and are required to enhance their understanding of securities laws and regulations [2]. - The company has fully repaid the non-operating fund occupation and is committed to improving internal controls and compliance to protect minority shareholders' rights [3]. Group 3: Upcoming Investor Communication - The company will hold a half-year performance briefing on October 14, 2025, to discuss its operational results and financial status, allowing investors to engage in Q&A [5][6]. - Investors can submit questions in advance from September 29 to October 13, 2025, through the Shanghai Stock Exchange Roadshow Center [6][9].

每经头条（nbdtoutiao）——5年增长33倍，这类新险种卖爆了，身边很多人都需要，30多家险企蜂拥而 入⋯⋯ （记者 曾健辉） 2024年1至12月份，日出东方的营业收入构成为：产品销售收入占比68.76%，供热及光伏工程占比 12.6%，特许经营项目占比11.77%，其他业务占比6.88%。 截至发稿，日出东方市值为78亿元。 每经AI快讯，2025年9月26日，上交所对日出东方（SH 603366，收盘价：9.55元）及其控股股东太阳雨 控股集团有限公司、关联方西藏隆晟能源管理有限公司及有关责任人予以通报批评：经查明，根据日出 东方控股股份有限公司于2025年4月30日披露的《2024年年度报告》《2024年非经营性资金占用及其他 关联资金往来情况专项说明》，及2025年8月28日披露的《关于2024年度非经营性资金占用相关数据的 更正公告》，2024年度，公司全资子公司西藏日出东方阿康清洁能源有限公司向公司控股股东太阳雨控 股集团有限公司同一控制下企业西藏隆晟能源管理有限公司提供借款，累计发生额约2759万元，2024年 12月31日借款余额约55万元；截至2025年1月27日，相关借款余额为0。 ...

Group 1 - Dongxing Medical plans to acquire 90% equity of Wuhan Yijiaobao for cash, which is expected to constitute a major asset restructuring [1] - Fosun Pharma's subsidiary plans to transfer 100% equity of Shanghai Cloning, with a transaction value of up to 1.256 billion yuan [1] Group 2 - *ST Songfa's subsidiary signed a shipbuilding contract worth approximately 400-600 million USD for four VLCCs, expected delivery between late 2026 and mid-2027 [3] - Qibin Group obtained financing support of up to 90 million yuan for share repurchase [4] Group 3 - Shapuaisi's shareholder plans to reduce holdings by up to 3% of the company's total shares [5] - *ST Kaixin intends to use up to 310 million yuan for cash management in safe and liquid financial products [6] Group 4 - Junchen Technology's shareholders plan to transfer 2.5% of the company's shares due to personal funding needs [7] - Jingliang Holdings received an administrative regulatory measure from Hainan Securities Regulatory Bureau for improper revenue recognition involving 299 million yuan [7] Group 5 - Tongcheng Holdings received a cash dividend of 24.6643 million yuan from Changsha Bank [9] - Shenyang Chemical appointed Chen Liguo as the new general manager [10] Group 6 - Huaguang Huaneng signed a contract for a 160 million yuan waste heat boiler project [15] - Shuxian Valley's subsidiary completed the re-registration of a health food product [16] Group 7 - Xuanta Pharmaceutical's new specification for a diabetes treatment drug was approved [17] - Panlong Pharmaceutical's application for a pain relief gel patch was accepted by the drug regulatory authority [18] Group 8 - Zhiguang Electric's subsidiary won a procurement contract worth 164 million yuan for a storage system [19] - Chitianhua's production facility resumed operations after maintenance [20] Group 9 - Haitong Development's application for a specific A-share issuance was accepted by the Shanghai Stock Exchange, aiming to raise 210 million yuan [20] - Risheng Technology's shareholders plan to transfer 4.02% of the company's shares [33] Group 10 - Pingmei Shares' controlling shareholder plans a strategic restructuring with Henan Energy Group [35] - Shenghui Integration's controlling shareholder committed not to reduce shareholdings for 12 months [37] Group 11 - Agricultural Bank and Bank of China will no longer establish supervisory boards, with their functions transferred to the audit committees [39][40] - Dongfang Yuhong's subsidiary signed a contract for a seawater pipeline project worth 2.524 billion USD [40][41] Group 12 - Ganfeng Lithium plans to introduce investors for a capital increase of up to 2.5 billion yuan [50] - Hanyu Pharmaceutical intends to raise up to 968 million yuan for various projects [51]

经查明，根据日出东方控股股份有限公司于2025年4月30日披露的《2024年年度报告》《2024年非经营 性资金占用及其他关联资金往来情况专项说明》，及2025年8月28日披露的《关于2024年度非经营性资 金占用相关数据的更正公告》，2024年度，公司全资子公司西藏日出东方阿康清洁能源有限公司向公司 控股股东太阳雨控股集团有限公司同一控制下企业西藏隆晟能源管理有限公司提供借款，累计发生额 27,586,265.53元，2024年12月31日借款余额551,606.15元；截至2025年1月27日，上述借款余额为0。对 日出东方控股股份有限公司、控股股东太阳雨控股集团有限公司、关联方西藏隆晟能源管理有限公司、 时任董事长徐新建、时任总经理万旭昶、时任财务总监徐忠、时任董事会秘书丁玮予以通报批评。 ...

证券代码：603366 证券简称：日出东方 公告编号：2025-029 日出东方控股股份有限公司 关于召开 2025 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025 年 10 月 14 日（星期二）14:00-15:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 （二）会议召开地点：上证路演中心 （三）会议召开方式：上证路演中心网络互动 三、参加人员 董事长兼董事会秘书（代行）：徐新建 总经理：万旭昶 投资者可于 2025 年 9 月 29 日（星期一）至 10 月 13 日（星期一）16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 zqb@solareast.com 进行提问。公司将在说明会上对投资者普遍关注的问题进行 回答。 日出东方控股股份有限公司（以下简称"公司"）已于 2025 ...

证券代码：603366 证券简称：日出东方 公告编号：2025-028 日出东方控股股份有限公司 关于公司、控股股东及相关人员收到 江苏证监局警示函的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 日出东方控股股份有限公司（以下简称"公司"）于近日收到中国证券监督 管理委员会江苏监管局（以下简称"江苏证监局"）下发的行政监管措施决定书 《江苏证监局关于对日出东方控股股份有限公司、太阳雨控股集团有限公司、徐 新建、万旭昶、徐忠、丁玮采取出具警示函措施的决定》（〔2025〕169 号）（以 下简称《警示函》）。根据相关要求，现将《警示函》主要内容公告如下： 二、其他说明 公司及相关人员高度重视上述《警示函》所指出的问题，深刻反思，严格整 改。《警示函》中涉及的非经营性资金占用款项已全部清偿，公司将进一步规范 与关联方之间的资金往来，严格落实管理制度，加强内部控制，切实保护中小股 东权益。同时，公司还将加强相关人员对法律法规、监管规则的学习，提高公司 规范运作水平及信息披露质量，杜绝此类事件再次发生。公司及全体董事、高级 ...

Core Viewpoint - Recently, Sunrise Oriental Holdings Co., Ltd. received a warning letter from Jiangsu Securities Regulatory Bureau regarding non-operating fund occupation due to loans provided to a subsidiary of the controlling shareholder [1] Group 1 - From April to December 2024, the company's subsidiary provided loans totaling 27.5863 million yuan to the controlling shareholder's subsidiary, with a year-end balance of 551,600 yuan [1] - This situation constitutes non-operating fund occupation, and the company failed to disclose this information in a timely manner [1] - As of the end of January 2025, the loans have been fully repaid, and the company, controlling shareholder, and related personnel have received a warning letter that will be recorded in their integrity files [1] Group 2 - The company and related personnel will implement strict rectification measures, standardize fund transactions, and enhance learning to prevent similar incidents from occurring in the future [1] - The regulatory measures taken do not affect the normal operations of the company [1]

Market Overview - The Shanghai Composite Index closed at 3821.83 points, with a decline of 0.18% [1] - The total trading volume of A-shares reached 25,184.71 billion yuan [1] Technical Analysis - A total of 171 A-shares experienced a death cross, where the 5-day moving average fell below the 10-day moving average [1] - Notable stocks with significant distance between their 5-day and 10-day moving averages include: - Innovation Medical: 5-day MA at 22.60 yuan, 10-day MA at 23.25 yuan, a difference of -2.80% [1] - Xiangyu Medical: 5-day MA at 54.48 yuan, 10-day MA at 55.33 yuan, a difference of -1.54% [1] - Northern Long Dragon: 5-day MA at 122.21 yuan, 10-day MA at 123.92 yuan, a difference of -1.38% [1] Stock Performance - Key stocks with notable declines include: - Innovation Medical: down 2.97% with a turnover rate of 16.99% [1] - Xiangyu Medical: down 5.95% with a turnover rate of 2.14% [1] - Northern Long Dragon: down 2.23% with a turnover rate of 20.67% [1] - Other stocks with significant declines include: - Aorui: down 5.25% [1] - Changbai Mountain: down 7.15% [1] - Hengbao Shares: down 6.73% [1]